Results 31 to 40 of about 420,674 (194)

Evidence of profound ovarian suppression on combined hormonal contraception resulting in dramatically different ovarian reserve testing and oocyte retrieval outcomes: case report and review of the literature

F&S Reports, 2020
Objective: To describe a case report and demonstrate that degree of ovarian suppression with continuous combined hormonal contraception (CHC) may be more profound than previously described and may present similarly as decreased ovarian reserve.
Chelsea W. Fox, M.D., Jamie Stanhiser, M.D., M.S.C.R., Alexander M. Quaas, M.D., Ph.D.   +2 more
doaj   +1 more source

RELATION OF ANTIMÜLLERIAN, FOLLICULAR STIMULATING HORMONE AND ANTRAL FOLLICLE COUNT ON INTRACYTOPLASMIC SPERM INJECTION OUTCOME IN INFERTILE PATIENTS

The Iraqi Journal of Medical Sciences, 2016
Background:Studying some of fertility-related hormones is of major benefit to identify the causative factors and to search for an appropriate treatment. Anti-müllerian hormone regarded as quantitative markers for ovarian reserve.
Menal F. Farhood, Farqad B. Hamdan, Anam R. Al-Salihi   +2 more
doaj   +4 more sources

Can Anti-Müllerian hormone predict the diagnosis of polycystic ovary syndrome? : A systematic review and meta-analysis of extracted data [PDF]

, 2013
Context: Existing biochemical tests for polycystic ovary syndrome (PCOS) have poor sensitivity and specificity. Many women with PCOS have high anti-Müllerian hormone (AMH) concentrations; thus, this may be a useful addition to the diagnostic criteria ...
Iliodromiti, S., Kelsey, Tom, Iliodromiti, Stamatina, Anderson, R.A., Nelson, Scott, Kelsey, T.W., Anderson, Richard, Nelson, S.M., Kelsey, Tom; id_orcid   +8 more
core   +1 more source

The Diagnostic Performance of Antimullerian Hormone for Polycystic Ovarian Syndrome and Polycystic Ovarian Morphology

Archives of Gynecology and Obstetrics, 2022
Abstract Purpose: The diagnosis of polycystic ovary syndrome (PCOS) remains a challenge to clinicians due to heterogeneous clinical presentation and diagnostic criteria. This study investigated the utilization of Anti-Müllerian hormone (AMH) alone or replacing polycystic ovarian morphology (PCOM) in the PCOS diagnostic criteria.Methods: A total
Fisun Vural, Birol Vural, Eyupcan Kardaş, Ayşe Deniz Ertürk Coşkun, İrem Yildirim   +4 more
openaire   +2 more sources

AntiMüllerian Hormone Level in Laparoscopic Cystectomy

Indonesian Journal of Obstetrics and Gynecology, 2016
Objective: To evaluate the impact of laparoscopic cystectomy using cautery and suturing technique on the ovarian reserve represented by the level of Anti-Müllerian Hormone (AMH) serum.
Edwin Budipramana, Nusratuddin Abdullah, Telly Tessy   +2 more
doaj   +1 more source

Persistent Mullerian duct syndrome (PMDS): Case report and review of literature

Urology Case Reports, 2022
Persistent Mullerian duct syndrome (PMDS) is a rare form of male pseudohermaphroditism (MPH) which characterized by the presence of uterus, fallopian tubes and upper part of vagina in an otherwise normally differentiated 46, XY male.
Abdullah B. Alanazi, Afrah Aldhowayan, Mousa M. Almuhanna, Abdullah M. Alghamdi   +3 more
doaj   +1 more source

Antimullerian hormone is a predictor of live birth in patients with recurrent pregnancy loss. [PDF]

Fertil Res Pract, 2019
Ovarian reserve testing is not routinely performed in the evaluation of recurrent pregnancy loss (RPL). The objective of this study was to determine if AMH levels are predictive of live birth rate in RPL patients pursuing expectant management (EM).Retrospective cohort study of RPL patients.
Murugappan G, Shahine L, Lathi RB.
europepmc   +4 more sources

Clinical practice guidelines for endometriosis in Japan (The 3rd edition)

, 2022
Journal of Obstetrics and Gynaecology Research, Volume 48, Issue 12, Page 2993-3044, December 2022.
Tasuku Harada, Fuminori Taniguchi, Michio Kitajima, Jo Kitawaki, Kaori Koga, Mikio Momoeda, Taisuke Mori, Takashi Murakami, Hisashi Narahara, Yutaka Osuga, Ken Yamaguchi   +10 more
wiley   +1 more source

Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer [PDF]

, 2013
Aim: Improving survival for women with early breast cancer (eBC) requires greater attention to the consequences of treatment, including risk to ovarian function. We have assessed whether biochemical markers of the ovarian reserve might improve prediction
Anderson, Richard A., Kelsey, Tom, Rosendahl, Mikkel, Kelsey, Thomas W., Anderson, Richard, Cameron, David A., Cameron, David, Kelsey, Tom; id_orcid   +7 more
core   +1 more source

A validated model of serum Anti-Müllerian hormone from conception to menopause [PDF]

, 2011
<p><b>Background:</b> Anti-Mullerian hormone (AMH) is a product of growing ovarian follicles. The concentration of AMH in blood may also reflect the non-growing follicle (NGF) population, i.e.
Kelsey, Tom, Richard A. Anderson, W. Hamish B Wallace, Wallace, W Hamish B, Thomas W. Kelsey, Phoebe Wright, Wright, P., Nelson, Scott M, Wallace, W.H.B., Nelson, S.M., Anderson, Richard, Scott M. Nelson, Thomas W Kelsey, Richard A Anderson, W Hamish B Wallace, Anderson, Richard A, Wallace, Hamish, Anderson, R.A., Wright, Phoebe, Nelson, Scott, Kelsey, Thomas W, Kelsey, T.W., Scott M Nelson, Nelson Scott M., Wright Phoebe, Wallace W. Hamish B, Kelsey Thomas W., Anderson Richard A., Kelsey, Tom; id_orcid   +28 more
core   +1 more source